Rytelo is approved for low-risk MDS patients with transfusion-dependent anemia, excluding those with isolated deletion 5q. Phase 3 IMerge trial data demonstrated significant reduction in red blood ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses findings from the phase 3 Precision-T trial of Orca-T in acute leukemia and ...

Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...

The biotech has launched a strategic review to consider options, including a possible sale, following shareholder pressure.

MDS are a group of closely related blood cancers ... However, frequent transfusions are associated with an increased risk of iron overload, transfusion reactions, and infections in themselves.

MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with ...

Imetelstat is approved for patients with lower risk MDS who have anemia (low red blood cells) and who cannot receive certain drugs designed to stimulate blood cell production (erythropoiesis ...

The latest trend in health and fitness tracking may sound familiar: wearing continuous glucose monitors (CGMs). Many people with diabetes use these devices, which measure blood-sugar levels in real ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Ophthalmologists specialize in wet AMD diagnosis and treatment. Learn about first steps toward diagnosis and treatment.